Janux Therapeutics, Inc. - Common Stock (JANX)
CUSIP: 47103J105
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,117,449
- Total 13F shares
- 29,548,436
- Share change
- +658,733
- Total reported value
- $400,093,845
- Price per share
- $13.54
- Number of holders
- 45
- Value change
- +$8,918,649
- Number of buys
- 19
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 47103J105?
CUSIP 47103J105 identifies JANX - Janux Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 47103J105:
Top shareholders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
14%
|
8,670,644
|
$105,869,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
9.7%
|
5,825,703
|
$71,132,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director |
4.7%
|
2,836,386
|
$34,632,000 | — | 30 Jun 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.5%
|
2,127,797
|
$25,966,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.1%
|
1,853,432
|
$22,630,000 | — | 30 Jun 2022 | |
| Bregua Corp |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,749,250
|
$22,008,098 | — | 15 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
2.4%
|
1,470,334
|
$17,953,000 | — | 30 Jun 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.4%
|
1,421,319
|
$17,354,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
1,208,354
|
$14,754,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
649,640
|
$7,932,000 | — | 30 Jun 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.74%
|
446,266
|
$5,449,000 | — | 30 Jun 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.67%
|
400,000
|
$4,884,000 | — | 30 Jun 2022 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.6%
|
360,414
|
$4,401,000 | — | 30 Jun 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
286,383
|
$3,497,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
283,620
|
$3,463,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
264,022
|
$3,224,000 | — | 30 Jun 2022 | |
| Cerity Partners LLC |
13F
|
Company |
0.25%
|
150,933
|
$1,843,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
133,157
|
$1,625,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
103,478
|
$1,264,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
74,873
|
$915,000 | — | 30 Jun 2022 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.08%
|
49,500
|
$566,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
42,510
|
$520,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
42,376
|
$517,000 | — | 30 Jun 2022 | |
| Parkwood LLC |
13F
|
Company |
0.06%
|
33,750
|
$412,000 | — | 30 Jun 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
29,640
|
$362,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
27,693
|
$337,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
25,518
|
$312,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
23,902
|
$292,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
15,864
|
$194,000 | — | 30 Jun 2022 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
10,614
|
$129,597 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
9,242
|
$113,000 | — | 30 Jun 2022 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
8,032
|
$98,000 | — | 30 Jun 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
8,013
|
$98,000 | — | 30 Jun 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
7,338
|
$90,000 | — | 30 Jun 2022 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
2,182
|
$27,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,151
|
$26,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,944
|
$24,000 | — | 30 Jun 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,440
|
$18,000 | — | 30 Jun 2022 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
1,382
|
$16,874 | — | 30 Jun 2022 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,014
|
$12,000 | — | 30 Jun 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
860
|
$11,000 | — | 30 Jun 2022 | |
| Daiwa Securities Group Inc. |
13F
|
Company |
0%
|
121
|
$1,000 | — | 30 Jun 2022 | |
| Crewe Advisors LLC |
13F
|
Company |
0%
|
115
|
$1,000 | — | 30 Jun 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
97
|
$1,000 | — | 30 Jun 2022 | |
| Shahram Salek-Ardakani |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
114,250
|
— | — | 03 Jan 2022 | |
| Peter A. Thompson |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 14 Jun 2022 | |
| Stefan Heller |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 14 Jun 2022 |
Institutional Holders of Janux Therapeutics, Inc. - Common Stock (JANX) as of Q3 2022
As of 30 Sep 2022,
Janux Therapeutics, Inc. - Common Stock (JANX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,548,436 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, CITADEL ADVISORS LLC, BVF INC/IL, EcoR1 Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, and 5AM Venture Management, LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
43
Q3 2022 holders
45
Holder diff
2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.